159 related articles for article (PubMed ID: 21476901)
1. Single injection results of endoscopic treatment of vesicoureteric reflux with different tissue-bulking substances in patients with end stage renal failure.
Dirim A; Hasirci E; Turunc T; Aygun C; Ozkardes H
J Endourol; 2011 May; 25(5):831-5. PubMed ID: 21476901
[TBL] [Abstract][Full Text] [Related]
2. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
Kirsch AJ; Perez-Brayfield MR; Scherz HC
J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.
Kocaoglu C
J Pediatr Surg; 2016 Oct; 51(10):1711-5. PubMed ID: 27117052
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.
Moore K; Bolduc S
J Urol; 2014 Dec; 192(6):1794-9. PubMed ID: 24928269
[TBL] [Abstract][Full Text] [Related]
5. The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux.
Taşkinlar H; Avlan D; Bahadir GB; Delibaş A; Nayci A
Int Braz J Urol; 2016; 42(3):514-20. PubMed ID: 27286115
[TBL] [Abstract][Full Text] [Related]
6. Subureteral dextranomer/hyaluronic acid copolymer injection for vesicoureteral reflux in transplant candidates.
Ozok U; Eroglu M; Imamoglu A; Bakirtaş H; Güvence N; Kiper A
J Endourol; 2005 Dec; 19(10):1185-7. PubMed ID: 16359211
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety in children with vesicoureteral reflux of a single injection of two different bulking agents--polydimethylsiloxane (Macroplastique) or dextranomer/hyaluronic acid copolymer (Deflux): a short-term prospective comparative study.
Kim SO; Shin BS; Hwang IS; Hwang EC; Oh KJ; Jung SI; Kang TW; Kwon D; Park K; Ryu SB
Urol Int; 2011; 87(3):299-303. PubMed ID: 21934268
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of endoscopic treatment of vesicoureteral reflux in children: comparison of different bulking agents.
Stredele RJ; Dietz HG; Stehr M
J Pediatr Urol; 2013 Feb; 9(1):71-6. PubMed ID: 22212178
[TBL] [Abstract][Full Text] [Related]
9. Renal transplant outcome after endoscopic treatment of vesicoureteral reflux using the subureteric injection of calcium hydroxyapatite.
Dirim A; Celik H; Hasirci E; Aygun C; Turunc T; Ozkardes H; Haberal M
Exp Clin Transplant; 2010 Mar; 8(1):45-8. PubMed ID: 20199370
[TBL] [Abstract][Full Text] [Related]
10. Ureteral Obstruction After Endoscopic Treatment of Vesicoureteral Reflux: Does the Type of Injected Bulking Agent Matter?
Friedmacher F; Puri P
Curr Urol Rep; 2019 Jul; 20(9):49. PubMed ID: 31289951
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic treatment of vesicoureteral reflux with polyacrylate polyalcohol copolymer and dextranomer/hyaluronic acid in adults.
Turk A; Selimoglu A; Demir K; Celik O; Saglam E; Tarhan F
Int Braz J Urol; 2014; 40(3):379-83. PubMed ID: 25010304
[TBL] [Abstract][Full Text] [Related]
12. A comparison between dextranomer/ hyaluronic acid and polyacrylate polyalcohol copolymer as bulking agents for treating primary vesicoureteral reflux.
Alizadeh F; Omidi I; Haghdani S; Hatef Khorrami M; Izadpanahi MH; Mohammadi Sichani M
Urol J; 2019 May; 16(2):174-179. PubMed ID: 30178456
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic vesicoureteral reflux correction in transplanted kidneys: does injection technique matter?
Yucel S; Akin Y; Celik O; Erdogru T; Baykara M
J Endourol; 2010 Oct; 24(10):1661-4. PubMed ID: 20626270
[TBL] [Abstract][Full Text] [Related]
14. Utility of dextranomer/hyaluronic acid injection in setting of bladder and ureteral anomalies.
Routh JC; Kramer SA; Inman BA; Ashley RA; Wolpert JJ; Vandersteen DR; Husmann DA; Reinberg Y
Urology; 2008 Mar; 71(3):435-8. PubMed ID: 18342182
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic treatment for vesicoureteral reflux: how important is technique?
Watters ST; Sung J; Skoog SJ
J Pediatr Urol; 2013 Dec; 9(6 Pt B):1192-7. PubMed ID: 23769202
[TBL] [Abstract][Full Text] [Related]
16. Prospective study using a new bulking agent for the treatment of vesicoureteral reflux: polyacrylamide hydrogel.
Cloutier J; Blais AS; Moore K; Bolduc S
J Urol; 2013 Sep; 190(3):1034-7. PubMed ID: 23538241
[TBL] [Abstract][Full Text] [Related]
17. Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.
Hunziker M; Mohanan N; Puri P
J Urol; 2013 May; 189(5):1876-81. PubMed ID: 23159268
[TBL] [Abstract][Full Text] [Related]
18. Learning from the learning curve: factors associated with successful endoscopic correction of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer.
Dave S; Lorenzo AJ; Khoury AE; Braga LH; Skeldon SJ; Suoub M; Farhat W; Pippi Salle JL; Bägli DJ
J Urol; 2008 Oct; 180(4 Suppl):1594-9; discussion 1599-600. PubMed ID: 18710756
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic treatment of vesicoureteral reflux in children: our experience and analysis of factors affecting success rate.
Alkan M; Ciftci AO; Senocak ME; Tanyel FC; Buyukpamukcu N
Urol Int; 2008; 81(1):41-6. PubMed ID: 18645270
[TBL] [Abstract][Full Text] [Related]
20. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection.
Routh JC; Reinberg Y; Ashley RA; Inman BA; Wolpert JJ; Vandersteen DR; Husmann DA; Kramer SA
J Urol; 2007 Oct; 178(4 Pt 2):1702-5; discussion 1705-6. PubMed ID: 17707019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
